PubMed:35908570
Annnotations
maxiaofeng52_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-12 | CI | denotes | Upadacitinib |
| T2 | 174-186 | CI | denotes | Upadacitinib |
| T3 | 1064-1076 | CI | denotes | upadacitinib |
| T4 | 332-344 | CI | denotes | upadacitinib |
| T5 | 2160-2172 | CI | denotes | upadacitinib |
| T6 | 2241-2253 | CI | denotes | upadacitinib |
| T7 | 2394-2406 | CI | denotes | upadacitinib |
| T8 | 2826-2838 | CI | denotes | upadacitinib |
| T9 | 3031-3043 | CI | denotes | upadacitinib |
| T10 | 2606-2618 | CI | denotes | upadacitinib |
| T11 | 3406-3418 | CI | denotes | Upadacitinib |
| T12 | 3135-3147 | CI | denotes | upadacitinib |
| T13 | 3366-3378 | CI | denotes | upadacitinib |
| T14 | 3583-3595 | CI | denotes | upadacitinib |
| T15 | 509-516 | CI | denotes | placebo |
| T16 | 127-134 | CI | denotes | placebo |
| T17 | 1097-1104 | CI | denotes | placebo |
| T18 | 2421-2428 | CI | denotes | placebo |
| T19 | 2194-2201 | CI | denotes | placebo |
| T20 | 2656-2663 | CI | denotes | placebo |
| T21 | 2275-2282 | CI | denotes | placebo |
| T22 | 3086-3093 | CI | denotes | placebo |
| T23 | 2881-2888 | CI | denotes | placebo |
| T24 | 3523-3530 | CI | denotes | placebo |
| T25 | 3212-3219 | CI | denotes | placebo |
| T27 | 34-81 | DP | denotes | active non-radiographic axial spondyloarthritis |
| T28 | 417-457 | DP | denotes | non-radiographic axial spondyloarthritis |
| T29 | 811-858 | DP | denotes | active non-radiographic axial spondyloarthritis |
| T30 | 2042-2089 | DP | denotes | active non-radiographic axial spondyloarthritis |
| T31 | 348-388 | DP | denotes | non-radiographic axial spondyloarthritis |
| T32 | 3468-3508 | DP | denotes | non-radiographic axial spondyloarthritis |
| T33 | 3641-3688 | DP | denotes | active non-radiographic axial spondyloarthritis |
wangzhuo19_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 34-81 | DP | denotes | active non-radiographic axial spondyloarthritis |
| T10 | 3468-3508 | DP | denotes | non-radiographic axial spondyloarthritis |
| T11 | 0-12 | CI | denotes | Upadacitinib |
| T12 | 174-186 | CI | denotes | Upadacitinib |
| T13 | 3406-3418 | CI | denotes | Upadacitinib |
| T14 | 332-344 | CI | denotes | upadacitinib |
| T15 | 1064-1076 | CI | denotes | upadacitinib |
| T16 | 2160-2172 | CI | denotes | upadacitinib |
| T17 | 2241-2253 | CI | denotes | upadacitinib |
| T18 | 2394-2406 | CI | denotes | upadacitinib |
| T19 | 2606-2618 | CI | denotes | upadacitinib |
| T2 | 811-858 | DP | denotes | active non-radiographic axial spondyloarthritis |
| T20 | 2826-2838 | CI | denotes | upadacitinib |
| T21 | 3031-3043 | CI | denotes | upadacitinib |
| T22 | 3135-3147 | CI | denotes | upadacitinib |
| T23 | 3366-3378 | CI | denotes | upadacitinib |
| T24 | 3583-3595 | CI | denotes | upadacitinib |
| T3 | 2042-2089 | DP | denotes | active non-radiographic axial spondyloarthritis |
| T4 | 3641-3688 | DP | denotes | active non-radiographic axial spondyloarthritis |
| T5 | 348-388 | DP | denotes | non-radiographic axial spondyloarthritis |
| T7 | 417-457 | DP | denotes | non-radiographic axial spondyloarthritis |
| T25 | 127-134 | CI | denotes | placebo |
| T26 | 509-516 | CI | denotes | placebo |
| T27 | 1097-1104 | CI | denotes | placebo |
| T28 | 2194-2201 | CI | denotes | placebo |
| T29 | 2275-2282 | CI | denotes | placebo |
| T30 | 2421-2428 | CI | denotes | placebo |
| T31 | 2656-2663 | CI | denotes | placebo |
| T32 | 2881-2888 | CI | denotes | placebo |
| T33 | 3086-3093 | CI | denotes | placebo |
| T34 | 3212-3219 | CI | denotes | placebo |
| T35 | 3523-3530 | CI | denotes | placebo |